29 January 2008
Hypertrophic change of facet joint in the cervical spine
Koichiro MorishitaBCDE, Yuichi KasaiAE, Atsumasa UchidaBFMed Sci Monit 2008; 14(2): CR62-64 :: ID: 734751
Abstract
Background
There have been few studies on degenerative changes of the cervical facet joint. This study was conducted to examine the image and clinical characteristics of patients with cervical facet hypertrophy and the significance of such characteristics.
Material and Method
The subjects were 215 patients with degenerative disease of the cervical spine, and they were divided into a hypertrophic change (+) group (32 patients) and a hypertrophic change (-) group (183 patients). We defined that if the distance between the tangential line on the posterior border of the vertebral body and the tip of the superior articular process was 7 mm or over by CT, it was regarded as hypertrophic change (+). Data was analyzed using Fisher's exact test, and differences were considered significant at p<0.05.
Results
The level at which hypertrophic change of the facet joint was observed was C3/4 in eight patients, C4/5 in 14, C5/6 in six, C6/7 in one, C3/4 + C4/5 in one, and C4/5 + C5/6 in two. Of the 32 patients in the hypertrophic change (+) group, 30 had an unilateral hypertrophic change. There was a significantly (p<0.05) greater proportion (28 of 32 patients, 87.5%) of males in the hypertrophic change (+) group than in the hypertrophic change (-) group, and neck pain was observed significantly more frequently in the hypertrophic change (+) group (25 of 32 patients, 78.1%).
Conclusions
The results showed that hypertrophic change of the facet joint occurred at mid-level of the cervical spine, usually unilaterally, was more frequent in males, and was associated with neck pain.
Keywords: Spinal Diseases - radiography, Radiculopathy - radiography, Ossification of Posterior Longitudinal Ligament - radiography, Intervertebral Disc Displacement - radiography, Hyperostosis - radiography, Tomography, X-Ray Computed, Cervical Vertebrae - radiography, Aged, 80 and over
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952